Position in LH
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,270,000
+$222,226 QoQ
Shares Held
15,250
+0.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#259
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $12,663,012 across 6 Diagnostics & Research names. LH ranks #1 (33.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
This page
|
15,250 | $4,270,000 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
6,670 | $3,344,070 | |
| 3 | DHR |
Danaher Corp /De/
|
16,597 | $3,161,396 | |
| 4 | WAT |
Waters Corp /De/
|
5,008 | $1,878,200 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
25 | $4,830 | |
| 6 | A |
Agilent Technologies, Inc.
|
34 | $4,516 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,270,000 | 15,250 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $4,047,774 | 15,171 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,019,097 | 16,020 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $4,623,100 | 16,105 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,360,290 | 16,610 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,992,188 | 17,153 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,864,500 | 16,852 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,800,053 | 17,004 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,438,504 | 16,896 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||